Rhythm Pharmaceuticals, Inc.
RYTMNasdaqCIK 1649904HealthcareFiscal year ends Dec 31
Reports and events: 172 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0420:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-052533 |
| 2026-08-0411:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052170 |
| 2026-06-2520:46 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-045569 |
| 2026-06-1520:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043170 |
| 2026-05-0520:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-030549 |
| 2026-05-0511:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030136 |
| 2026-04-2920:09 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001628280-26-028375 |
| 2026-04-0319:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-023606 |
| 2026-03-2620:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-021414 |
| 2026-03-2013:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019995 |
| 2026-03-1620:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-018211 |
| 2026-03-0211:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021801 |
| 2026-02-2622:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012399 |
| 2026-02-2612:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011987 |
| 2026-01-0914:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001459 |
| 2025-12-1921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-123108 |
| 2025-12-1112:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120141 |
| 2025-11-0713:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-108154 |
| 2025-11-0421:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-106264 |
| 2025-11-0412:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105904 |
| 2025-08-0520:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010302 |
| 2025-08-0511:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010176 |
| 2025-07-1111:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067133 |
| 2025-07-0920:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-066724 |
| 2025-06-2620:55 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008924 |
| 2025-05-0720:46 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006765 |
| 2025-05-0711:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006602 |
| 2025-04-2920:01 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001558370-25-005818 |
| 2025-04-0711:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004507 |
| 2025-03-2020:05 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-003374 |
| 2025-02-2813:21 ET | 8-K | 8.01 Other events | 0001558370-25-001891 |
| 2025-02-2813:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001889 |
| 2025-02-2612:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-001553 |
| 2025-01-1012:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000093 |
| 2024-11-0613:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014532 |
| 2024-11-0521:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-114304 |
| 2024-09-1920:49 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-101393 |
| 2024-08-1420:06 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-06-30 | 0001410578-24-001438 |
| 2024-08-0620:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011101 |
| 2024-08-0611:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086081 |
| 2024-07-1020:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-078941 |
| 2024-06-1721:19 ET | 8-K | 8.01 Other events | 0001104659-24-072376 |
| 2024-05-0720:43 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007076 |
| 2024-05-0711:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-057691 |
| 2024-04-3023:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000413 |
| 2024-04-2620:05 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001104659-24-052915 |
| 2024-04-1720:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-099106 |
| 2024-04-1611:00 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-047492 |
| 2024-04-0322:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-086172 |
| 2024-04-0121:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-041970 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.